Related Experiment Videos
Direct and reversible inhibition of platelet factor 4 on megakaryocyte development from CD34+ cord blood cells:
1Institut des Vaisseaux et du Sang, Hôpital Lariboisière, Paris, France.
Abstract:
Mechanisms of the action of platelet factor 4 (PF4) on the growth of megakaryocyte (MK) progenitor cells in CD34+ cord blood (CB) cells were studied in comparison with transforming growth factor beta1 (TGFbeta1). Development of MK from CD34+ CB cells in both plasma clot culture and liquid culture was significantly inhibited by either purified human PF4 and by recombinant human TGFbeta1. Inhibition of MK colony formation by PF4 was reversible because CD34+ cells preincubated with PF4 could regenerate colonies after washing and replating into secondary cultures. In contrast, TGFbeta1-preincubated CD34+ cells gave rise to few colonies following replating. Moreover, incubation of CD34+ cells with PF4 in liquid culture caused the increased number of both stem cell factor (SCF)-binding cells and CD34 antigen-bearing cells. In addition, PF4-preincubated CD34+ cells exhibited a higher potential in MK colony formation in the presence of 5-fluorouracil (5FU). These results demonstrate that both PF4 and TGFbeta1 inhibit MK development from CD34+ CB cells by different mechanisms, and suggest that PF4, unlike TGFbeta1, exerts its inhibitory effect on the growth of the target cells in a reversible manner which results in a preservation of a more immature and 5FU-resistant cell population.
Insights
Platelet factor 4 (PF4) and transforming growth factor beta1 (TGFbeta1) both inhibit megakaryocyte (MK) progenitor cell growth from CD34+ cord blood cells. PF4
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Megakaryocyte (MK) development from CD34+ cord blood (CB) cells is crucial for platelet production.
- Platelet factor 4 (PF4) and transforming growth factor beta1 (TGFbeta1) are implicated in hematopoietic regulation.
Purpose of the Study:
- To elucidate the distinct mechanisms by which PF4 and TGFbeta1 affect MK progenitor cell growth.
- To compare the reversible vs. irreversible effects of PF4 and TGFbeta1 on MK development.
Main Methods:
- CD34+ cord blood cells were cultured in plasma clot and liquid cultures.
- Cells were treated with purified human PF4 or recombinant human TGFbeta1.
- Colony formation assays, including secondary replating and 5-fluorouracil (5FU) resistance assays, were performed.
Main Results:
- Both PF4 and TGFbeta1 significantly inhibited MK colony formation.
- PF4-induced inhibition was reversible upon washing and replating, unlike TGFbeta1.
- PF4 treatment increased stem cell factor (SCF)-binding cells and CD34+ cells, preserving a 5FU-resistant population.
Conclusions:
- PF4 and TGFbeta1 inhibit MK development via different mechanisms.
- PF4's reversible inhibition preserves a more immature, drug-resistant CD34+ cell population.
- PF4 may play a distinct role in regulating hematopoietic stem cell fate compared to TGFbeta1.